News

EzFill's CFO Avishai Vaknin Sells Shares: A Financial Overview

EzFill's CFO Avishai Vaknin Sells Shares: A Financial Overview

EzFill Holdings' Recent Insider Stock Sale

EzFill Holdings Inc (NASDAQ: EZFL) recently witnessed an important transaction involving Avishai Vaknin, the Chief Technology Officer, who sold shares worth $29,180. This sale took place on two occasions, with share prices varying between $4.10 and $4.12.

Details of the Transactions

The insider sales took place on specific dates, totaling 7,100 shares sold. On the first occasion, two transactions were recorded on the same day: one for 1,100 shares and another for 1,000 shares, both at a price of $4.10. Just a few days later, Vaknin sold an additional 2,000 shares at $4.12, along with 4,000 shares priced between $4.11 and $4.12.

Current Shareholding Status

Even after these sales, Vaknin maintains a substantial stake in EzFill, holding around 73,933 shares. The filings indicate that these sales mainly aimed to address tax obligations.

Insights on Insider Selling

Insider sales often give investors insight into an executive’s perspective on the company's valuation and future potential. However, it’s not uncommon for executives to sell shares for reasons tied to personal financial planning or liquidity needs.

Company Overview

EzFill Holdings is involved in the retail-auto dealer and gasoline station sectors. Founded in Delaware, the company is headquartered in Miami. Anyone interested can reach out to them at 305-791-1169.

Recent Strategic Moves

To strengthen its market position, EzFill has recently made significant financial adjustments. One major step involved converting approximately $13.5 million of its debt into equity in collaboration with NextNRG Holding Corp and AJB Capital Investments. This strategic maneuver is expected to reduce annual interest obligations by about $1.2 million, while also enhancing cash reserves by $1.4 million from NextNRG's investment.

Financial Maneuvers for Growth

EzFill also obtained a $165,000 promissory note from NextNRG, aimed at bolstering working capital. This note starts with an 8% annual interest rate for the first nine months, increasing to 18% thereafter. If there's a default, NextNRG can demand an immediate payment of 150% of the outstanding amount or opt to convert the note into shares of EzFill.

Navigating Nasdaq Compliance

EzFill recently regained compliance with the Nasdaq Listing Rule 5550(b)(1), which requires maintaining a minimum equity of $2.5 million for stockholders. This was accomplished through various strategic actions, including a private placement of Series B Convertible Preferred Stock and the conversion of numerous debts into common and Series A Preferred stock.

Performance Highlights

In its latest report, EzFill announced record revenues exceeding $2.6 million, reflecting an impressive 32% increase compared to the previous year. Additionally, the company has effectively reduced net losses by 69%. These results are indicative of EzFill’s positive development.

Market Performance Insights

EzFill Holdings (NASDAQ: EZFL) is actively addressing financial challenges as seen in its market performance. As of Q2 2024, the current metrics reflect a market capitalization of $23.33 million, with a reported revenue increase of 27.26% over the past year, totaling $25.85 million. However, the company’s gross profit margin sits at a modest 6.72%, pointing to potential inefficiencies or elevated operating costs relative to revenues.

Analyst Perspectives

Analysts anticipate that EzFill will likely continue experiencing revenue growth this year, but it's facing rapid depletion of cash reserves and struggling with low gross profit margins. Such trends could be influencing actions like Avishai Vaknin's recent share sale. The volatility of the stock and shifting market trends further complicate the corporate landscape.

Dividend Considerations

It's important for potential investors to know that EzFill currently does not pay dividends, which might be a drawback for those looking for regular income from their investments. Prospective investors should seek comprehensive insights to get a clearer picture of EzFill's financial standing and stock prospects.

Frequently Asked Questions

What motivated Avishai Vaknin's recent stock sale?

Vaknin’s stock sale was primarily intended to cover tax liabilities, as noted in the disclosures related to the transaction.

How many shares does Avishai Vaknin still own after the sale?

After the sales, Vaknin retains about 73,933 shares in EzFill Holdings.

What recent financial maneuvers has EzFill undertaken?

EzFill converted $13.5 million of its debt into equity and secured additional financial backing from NextNRG to enhance its cash reserves.

How did EzFill perform financially in the last reported period?

In its most recent report, the company announced record revenues surpassing $2.6 million, reflecting a noteworthy 32% growth year-over-year.

Why might investors be cautious about EzFill's stock?

Investors might hesitate due to the company’s low gross profit margins and the lack of dividend payments, which could deter income-seeking investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading